This announcement is a separate document:
奥翔药业：奥翔药业关于控股股东、董事、高管暨持股平台减持计划提前终止暨后续减持计划的公告
Aoxiang Pharmaceutical: Aoxiang Pharmaceutical's announcement on the early termination of the holdings reduction plan for controlling shareholders, directors, executives and shareholding platforms and subsequent holdings reduction plans
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.